Currently, the only FDA-approved OTC weight loss drug is Alli, which uses a 60-milligram dose of orlistat versus 120 milligrams in its prescription counterpart, Xenical. Alli is approved for adults with a BMI over 25, whereas Xenical is approved for those with a BMI over 30 or over 27 with other risk factors like diabetes and hypertension.

GLP-1 medications—like Ozempic, Wegovy, and Zepbound—can help you shed pounds, but only if taken properly. Don't get caught making these semaglutide slip-ups.

Although not available in India in injectible form, new weight loss drugs Ozempic and Wegovy are all the rage. Lounge speaks to doctors about these ‘game-changers’

Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes. But data on the practice remain limited.

It seems as though Ozempic and other weight-loss jabs are everywhere – and the appetite for them shows no signs of slowing down – with the industry accelerating so fast it’s projected to be worth $100 billion within the next decade.

Food left in the stomach or stool left in the bowel can impede a doctor's ability to successfully perform an endoscopy or colonoscopy. Now, research finds this scenario is more likely if the patient is taking popular new weight-loss meds such as Ozempic,

In real-world settings multiple factors contribute to non-persistence, including adverse effects, high cost-sharing and weight loss not meeting patients' expectations.

New research suggests GLP-1 medications like Ozempic may help reduce several health risks in addition to treating type 2 diabetes and obesity.

A new study published in the journal JAMA Network Open found that food left in the stomach or stool left in the bowel can hinder a doctor’s ability to successfully perform an endoscopy or colonoscopy.